Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
CALL
Brookfield Infrastructure Partners
BIP
$17.9B
| $156K | ﹤0.01% |
10,080
+5,292
| +111% | +$80.8K |
|
5127
Columbia Banking Systems
COLB
$8.78B
| $156K | ﹤0.01% |
5,795
-18,446
| -76% | -$483K |
|
5128
CALL
Ingredion
INGR
$6.49B
| $156K | ﹤0.01% |
2,300
-100
| -4% | -$6.76K |
|
|
5129
PUT
Ingredion
INGR
$6.49B
| $156K | ﹤0.01% |
2,300
-200
| -8% | -$13.5K |
|
|
IRBT
5130
CALL
DELISTED
iRobot
IRBT
| $156K | ﹤0.01% |
4,600
-8,800
| -66% | -$300K |
|
5131
CALL
New York Times
NYT
$10.5B
| $156K | ﹤0.01% |
10,400
-1,400
| -12% | -$19K |
|
|
BPL
5132
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $156K | ﹤0.01% |
2,200
-2,800
| -56% | -$188K |
|
|
NAVB
5133
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $156K | ﹤0.01% |
3,914
+3,714
| +1,857% | +$145K |
|
|
MFRM
5134
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $155K | ﹤0.01% |
3,619
+1,117
| +45% | +$39.9K |
|
|
FTT
5135
DELISTED
FEDERATED ENHANCED TREAS INCM FD COM BEN INTEREST
FTT
| $155K | ﹤0.01% |
12,899
+3,744
| +41% | +$48.3K |
|
5136
GSI Technology
GSIT
$254M
| $154K | ﹤0.01% |
25,544
+2,836
| +12% | +$19.1K |
|
5137
CALL
IMAX
IMAX
$2.73B
| $154K | ﹤0.01% |
5,300
-4,000
| -43% | -$115K |
|
5138
PUT
Perdoceo Education
PRDO
$2.03B
| $154K | ﹤0.01% |
30,800
-2,400
| -7% | -$10.6K |
|
5139
CALL
ProShares Ultra Materials
UYM
$39.7M
| $154K | ﹤0.01% |
12,800
-72,400
| -85% | -$822K |
|
|
NATI
5140
DELISTED
National Instruments Corp
NATI
| $154K | ﹤0.01% |
4,777
+107
| +2% | +$3.3K |
|
|
ROSE
5141
PUT
DELISTED
ROSETTA RESOURCES INC
ROSE
| $154K | ﹤0.01% |
3,200
-14,700
| -82% | -$792K |
|
|
DRL
5142
DELISTED
DORAL FINANCIAL CORPORATION (NEW)
DRL
| $154K | ﹤0.01% |
10,295
+1,706
| +20% | +$28.9K |
|
|
FBRC
5143
DELISTED
FBR & Co. Common Stock
FBRC
| $154K | ﹤0.01% |
5,890
-1,411
| -19% | -$38K |
|
5144
PUT
IDEX
IEX
$17.2B
| $153K | ﹤0.01% |
2,100
-1,400
| -40% | -$97.3K |
|
5145
CALL
ING
ING
$102B
| $153K | ﹤0.01% |
10,900
-103,400
| -90% | -$1.32M |
|
5146
Plains GP Holdings
PAGP
$5.02B
| $153K | ﹤0.01% |
+2,210
| New | +$138K |
|
5147
Zebra Technologies
ZBRA
$17.2B
| $153K | ﹤0.01% |
2,822
+667
| +31% | +$33.4K |
|
|
MAGN
5148
Magnera Corp
MAGN
$446M
| $153K | ﹤0.01% |
435
-1,563
| -78% | -$554K |
|
|
STEL
5149
DELISTED
STELLARONE CORPORATION COM
STEL
| $153K | ﹤0.01% |
6,363
-144
| -2% | -$3.44K |
|
|
MZF
5150
DELISTED
Managed Duration Inv Grd Muni Fd
MZF
| $153K | ﹤0.01% |
12,778
+4,534
| +55% | +$56.3K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.